PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA)

Lobbying client. Federal LDA filings.

Connected on the graph

Inbound (4)

date	from	type	amount	source
—	Rick Desimone	lobbied_for	—	lda_lobbyist_client
—	Matthew Mcginley	lobbied_for	—	lda_lobbyist_client
2026-01-01	ADVANCED POLICY CONSULTING, LLC	lobbies_for	$40,000	lda_filing
2026-01-01	DESIMONE CONSULTING, LLC	lobbies_for	$30,000	lda_filing

Outbound (6)

date	type	to	amount	role	source
2026-01-01	lobbies_on_bill	HR 1492 — To amend title XI of the Social Security Act to equalize the negotiation period between sm	—	HR 1492	lobbying_bill_mention
2026-01-01	lobbies_on_bill	HR 2214 — DRUG Act	—	HR 2214	lobbying_bill_mention
2026-01-01	lobbies_on_bill	S 832 — EPIC Act of 2025	—	S.832	lobbying_bill_mention
2026-01-01	lobbies_on_bill	HR 4317 — PBM Reform Act of 2025	—	H.R.4317	lobbying_bill_mention
2026-01-01	lobbies_on_bill	HR 7148 — Consolidated Appropriations Act, 2026	—	H.R.7148	lobbying_bill_mention
2026-01-01	lobbies_on_bill	S 3345 — PBM Price Transparency and Accountability Act	—	S.3345	lobbying_bill_mention

Source id: 196261
General description: trade group representing U.S. pharmaceutical research and biotechnology companies
State: DC
Country: US
Principal place of business: US
Government-entity client: false
Effective date: 2012-02-06
Total spend (across 1 ingested filings): $30,000

Filings

Posted	Type	Year	Lobbying firm	Income
2026-04-14	`Q1`	2026	DESIMONE CONSULTING, LLC	$30,000

pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.